TradingView
zAngus
Dec 17, 2021 2:31 AM

Pfizer will dominate $28 billion COVID-pill market in 2022 

Pfizer, Inc.NYSE

Description

With the rapid spread of Omicron across the globe and the strong reluctance from Governments to shut down again, it will be interesting to see how quickly a Covid tablet will become available on mass.

Pfizer is tipped by a few different sources to be the likely one to take the lead.

Share price looks too hot at the moment so will keep an eye on it for a pullback.

Strong run at the moment.

Comment

Comment

Price has as expected pulled back into a better value area and one where importantly it has bounced off its 20 Day Moving Average previously - so have started to keep an eye on it again. Keep an eye out for the bounce.

Comments
simbha
PFE is currently under valuation correction. It means , retracements are short and small.
marinik
and that Cup and Handle, how did i missed it!?
hope for a retrace before it gets even higher! ;)
zAngus
@marinik, I like it, especially long term. Just feel right now has gone up so steeply must be a pullback sooner or later.
More